生髮补充剂和治疗产品市场－全球产业规模、份额、趋势、机会及按类型、地区和竞争格局分類的预测（2021-2031年）

全球生髮补充剂和治疗市场预计将从 2025 年的 76.5 亿美元增长到 2031 年的 111.2 亿美元，复合年增长率为 6.43%。

该市场涵盖一系列旨在促进头皮健康和激活毛囊的治疗设备、营养补充剂和药物製剂。主要成长要素包括全球老化人口中男性型脱髮症的日益普遍，以及人们对个人外表日益增长的心理关注。这导致人们越来越倾向于寻求在脱髮早期阶段就进行治疗以逆转脱髮。此外，饮食习惯的改变和压力水平的上升也扩大了潜在消费群体，从而催生了对传统使用者群体之外的有效治疗方法的需求。

近期产业数据显示，消费者对维持容颜活力有着浓厚的兴趣。例如，责任营养委员会 (CRN) 的报告指出，到 2024 年，美国 26% 的膳食补充剂使用者将服用专门用于促进皮肤、头髮和指甲健康的保健产品。儘管需求持续旺盛，但由于新药监管标准严格，市场仍面临许多挑战。这些严苛的要求显着延长了核准流程，可能延缓创新临床疗法的商业化。

市场驱动因素

直接面向消费者 (DTC) 的电子商务平台蓬勃发展，个人化治疗方案日益普及，从根本上改变了市场的可及性。透过利用远距远端医疗服务，企业现在可以直接向消费者提供客製化的营养保健品和处方级脱髮解决方案，从而有助于减少寻求治疗所带来的耻辱感。这种模式透过根据个人生理需求量身定制的订阅模式，有效提升了客户维繫，并扩大了市场覆盖范围。 Hims & Hers Health, Inc. 就是这趋势的有力佐证。该公司在 2024 年 11 月发布的「2024 年第三季财务业绩」中，宣布其订阅用户创下 200 万的历史新高。这项里程碑式的成就主要得益于对个人化医疗解决方案的需求，凸显了向数位化健康管理的转变，便利性有助于提高治疗依从性。

同时，非侵入性治疗方法技术的进步以及针对以往未被满足的医疗需求的新型药物的研发正在推动市场发展。该行业日益采用先进的免疫调节和生物技术治疗方法，尤其是在脱髮症等自体免疫疾病领域，而创业投资正支持这些治疗方法上市。例如，在2024年2月题为「Pelage Pharmaceuticals宣布完成1,675万美元A轮资金筹措」的新闻稿中，Perage Pharmaceuticals宣布已获得PP405的研发资金，PP405是一种活化休眠毛囊干细胞的外用药物。这些投资也得到了监管部门成功核准的支持。例如，美国食品药物管理局（FDA）于2024年核准了Sun Pharmaceutical Industries的LEQSELVI（用于治疗重度脱髮症），这大大扩展了可用的治疗选择。

市场挑战

对新药产品严格的监管要求是全球生髮补充剂和治疗市场发展的一大障碍。监管机构采用严格的测试通讯协定以确保产品的安全性和有效性，这不可避免地延长了新疗法的研发週期。漫长的核可阶段导致创新速度与实际上市速之间存在差距，迫使企业在无法产生收入的情况下长期投入资金。因此，先进配方的上市往往被推迟，限制了产业推出能够提升市场价值的新一代疗法的能力。

鑑于寻求毛髮修復服务的人数迅速增长，这种监管瓶颈尤其具有限制性。根据国际毛髮重建外科学会预测，到2024年，每位会员医生的平均患者数量预计将比2021年增长20%，这表明市场对有效治疗方法的需求强劲。然而，监管方面的延误阻碍了新型药物解决方案充分利用这一需求，使得该行业难以透过先进的产品上市，将消费者日益增长的兴趣立即转化为收入。

市场趋势

随着消费者越来越重视整体健康和安全，而非依赖合成药物疗法，洁净标示、纯素和植物来源处方笺在市场上取得了显着成长。为了顺应这一偏好转变，护髮产品正在重新设计，去除人工添加剂和激素，并采用标准化的植物成分来解决压力等根本原因，同时避免有害的副作用。领先天然品牌的持续出色表现，印证了这种向无药物功效方向转变的成功。例如，联合利华于2025年8月发布的《重返2025年上半年报告》指出，其旗下以植物来源品牌Nutrafol为首的健康事业部连续21个季度实现了强劲的两位数增长，凸显了消费者对天然、经科学验证的解决方案日益增长的需求。

同时，临床级家用生髮设备的普及，使得以往只有专科诊所才能享受到的先进再生疗法变得更加大众化。技术的微型化使得穿戴式装置得以大规模生产，这些装置采用先进的LED和低功率雷射疗法（LLLT），让使用者能够将专业级的效果与便捷的自主使用体验结合。随着越来越多的消费者寻求经济实惠、非侵入性的替代方案，以取代长期药物治疗和手术，该领域正在迅速发展。根据The Industry.beauty网站2025年9月发表的一篇报导《美容科技集团目标IPO估值3.2亿英镑》报道，美容科技集团（Beauty Tech Group）在2025财年上半年实现了27%的销售额增长，达到5520万英镑。这项成长主要得益于该公司家用生髮设备在全球的普及。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章：全球生髮补充剂和治疗产品市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（膳食补充剂、药品、医疗设备）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美生髮补充剂和治疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲生髮补充剂和治疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区生髮补充剂和治疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲生髮补充剂和治疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲生髮补充剂和治疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球生髮补充品与治疗产品市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Nutraceutical Wellness Inc.
• Viviscal Limited.
• GNC Holdings, Inc.
• Procter & Gamble
• InVite Health
• Johnson & Johnson Services, Inc
• Merck & Co., Inc.
• Curallux, LLC.
• iRestore Hair Growth System
• Lexington International, LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Hair Growth Supplement and Treatment Market is projected to expand from USD 7.65 Billion in 2025 to USD 11.12 Billion by 2031, reflecting a compound annual growth rate of 6.43%. This market sector comprises a wide variety of therapeutic devices, dietary supplements, and pharmaceutical formulations aimed at enhancing scalp health and stimulating hair follicles. Key growth drivers include a globally aging demographic increasingly prone to androgenetic alopecia, alongside a growing psychological focus on personal aesthetics that encourages individuals to pursue restorative treatments earlier in the thinning process. Additionally, shifting dietary patterns and rising stress levels have widened the potential consumer base, creating a need for effective remedies that extend beyond traditional user groups.

Recent industry data highlights a strong consumer dedication to maintaining aesthetic vitality. For instance, the Council for Responsible Nutrition reported that in 2024, 26% of dietary supplement users in the United States consumed products specifically meant to support the health of skin, hair, and nails. Despite this persistent demand, the market faces substantial obstacles due to rigorous regulatory standards for new pharmaceutical agents. These stringent requirements can extend approval timelines significantly, thereby slowing the commercialization of innovative clinical treatments.

Market Driver

The growth of direct-to-consumer e-commerce platforms and the rising uptake of personalized treatment plans are fundamentally transforming market accessibility. By utilizing telemedicine services, companies can now deliver customized nutraceuticals and prescription-strength hair loss solutions directly to consumers, helping to minimize the stigma often attached to seeking treatment. This approach promotes high customer retention through subscription models tailored to individual physiological requirements, effectively expanding the market reach. As evidence of this trend, Hims & Hers Health, Inc. reported in their 'Third Quarter 2024 Financial Results' in November 2024 that their subscriber base had reached a record 2.0 million, a milestone largely driven by the appetite for personalized health solutions, confirming a shift toward digital health management where convenience drives adherence.

Simultaneously, the market is being propelled by technological breakthroughs in non-invasive restoration and the development of novel pharmaceutical agents that target previously unmet medical needs. The industry is increasingly adopting sophisticated immunomodulatory and biotechnology-based treatments, specifically for autoimmune disorders such as alopecia areata, supported by venture capital funding dedicated to bringing these mechanisms to market. For example, Pelage Pharmaceuticals announced in a February 2024 press release titled 'Pelage Pharmaceuticals Announces $16.75 Million Series A Financing' that it had secured funding to develop PP405, a topical treatment aimed at reactivating dormant hair follicle stem cells. These investments are further validated by regulatory successes, such as the U.S. FDA's 2024 approval of Sun Pharmaceutical Industries Ltd.'s LEQSELVI for severe alopecia areata, which has significantly broadened the available therapeutic options.

Market Challenge

Rigorous regulatory mandates regarding novel pharmaceutical agents represent a major hurdle for the Global Hair Growth Supplement and Treatment Market. Regulatory bodies enforce strict testing protocols to ensure both safety and efficacy, a process that inevitably extends the development timeline for new clinical therapies. This protracted approval phase creates a gap between the speed of innovation and actual market availability, compelling companies to sustain long periods of capital spending without generating revenue. Consequently, the launch of advanced formulations is often postponed, restricting the industry's capacity to debut next-generation therapies that could otherwise enhance market valuation.

This regulatory bottleneck is particularly constraining given the rapidly increasing number of individuals seeking restoration services. According to the International Society of Hair Restoration Surgery, the average patient volume per member physician rose by 20% in 2024 compared to 2021 levels, indicating a strong desire for effective treatments. However, because regulatory slowdowns hinder the market from fully capitalizing on this demand with new pharmaceutical solutions, the industry finds it difficult to immediately translate this heightened consumer interest into revenue through advanced product introductions.

Market Trends

The market is experiencing a notable rise in clean label, vegan, and plant-based formulations as consumers increasingly value holistic wellness and safety over synthetic pharmacotherapy. This preference is prompting the reformulation of hair health products to eliminate artificial additives and hormones, utilizing standardized botanicals instead to address root causes such as stress without causing adverse side effects. The success of this shift toward drug-free efficacy is demonstrated by the enduring performance of major natural brands; for instance, Unilever's 'What's behind Unilever's first half results?' report from August 2025 noted that its Wellbeing business group, led by the plant-based brand Nutrafol, achieved strong double-digit growth for the 21st consecutive quarter, underscoring the demand for nature-derived, scientifically validated solutions.

In parallel, the widespread availability of clinical-grade at-home hair growth devices is democratizing access to advanced restoration therapies that were once limited to professional clinics. Technological miniaturization has facilitated the mass production of sophisticated LED and low-level laser therapy (LLLT) wearables, providing users with professional-level results alongside the convenience of autonomous use. This sector is growing rapidly as consumers look for cost-effective, non-invasive alternatives to long-term medication or surgical procedures. According to an article by The Industry.beauty in September 2025 titled 'Beauty Tech Group targets £320m valuation ahead of stock market debut', the Beauty Tech Group saw sales increase by 27% to £55.2 million in the first half of 2025, a growth spur fueled by the rising global adoption of its at-home hair restoration devices.

Key Market Players

• Nutraceutical Wellness Inc.
• Viviscal Limited.
• GNC Holdings, Inc.
• Procter & Gamble
• InVite Health
• Johnson & Johnson Services, Inc
• Merck & Co., Inc.
• Curallux, LLC.
• iRestore Hair Growth System
• Lexington International, LLC

Report Scope

In this report, the Global Hair Growth Supplement and Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hair Growth Supplement and Treatment Market, By Type

• Supplements
• Pharmaceuticals
• Devices

Hair Growth Supplement and Treatment Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hair Growth Supplement and Treatment Market.

Available Customizations:

Global Hair Growth Supplement and Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hair Growth Supplement and Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Supplements, Pharmaceuticals, Devices)
  • 5.2.2. By Region
  • 5.2.3. By Company (2025)
• 5.3. Market Map

6. North America Hair Growth Supplement and Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hair Growth Supplement and Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
  • 6.3.2. Canada Hair Growth Supplement and Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
  • 6.3.3. Mexico Hair Growth Supplement and Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type

7. Europe Hair Growth Supplement and Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hair Growth Supplement and Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
  • 7.3.2. France Hair Growth Supplement and Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
  • 7.3.3. United Kingdom Hair Growth Supplement and Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
  • 7.3.4. Italy Hair Growth Supplement and Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
  • 7.3.5. Spain Hair Growth Supplement and Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type

8. Asia Pacific Hair Growth Supplement and Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hair Growth Supplement and Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
  • 8.3.2. India Hair Growth Supplement and Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
  • 8.3.3. Japan Hair Growth Supplement and Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
  • 8.3.4. South Korea Hair Growth Supplement and Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
  • 8.3.5. Australia Hair Growth Supplement and Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type

9. Middle East & Africa Hair Growth Supplement and Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hair Growth Supplement and Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
  • 9.3.2. UAE Hair Growth Supplement and Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
  • 9.3.3. South Africa Hair Growth Supplement and Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type

10. South America Hair Growth Supplement and Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hair Growth Supplement and Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
  • 10.3.2. Colombia Hair Growth Supplement and Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
  • 10.3.3. Argentina Hair Growth Supplement and Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hair Growth Supplement and Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Nutraceutical Wellness Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Viviscal Limited.
• 15.3. GNC Holdings, Inc.
• 15.4. Procter & Gamble
• 15.5. InVite Health
• 15.6. Johnson & Johnson Services, Inc
• 15.7. Merck & Co., Inc.
• 15.8. Curallux, LLC.
• 15.9. iRestore Hair Growth System
• 15.10. Lexington International, LLC

16. Strategic Recommendations

17. About Us & Disclaimer